Literature DB >> 1437439

Detection of IgM rheumatoid factors by enzyme-linked immunosorbent assay in children with juvenile rheumatoid arthritis: correlation with articular disease and laboratory abnormalities.

J N Jarvis1, T Pousak, M Krenz.   

Abstract

This study was undertaken to determine the clinical relevance of IgM rheumatoid factors (RFs) detected by enzyme-linked immunosorbent assay (ELISA) in children with juvenile rheumatoid arthritis (JRA) by examining their association with severity of acute articular disease. ELISAs for IgM-RF were performed on serum specimens from 65 children with JRA. Activity of articular disease was estimated by an arbitrary scoring system. Significant differences were seen in articular disease activity between the group of children with polyarticular disease who were IgM-RF-positive by ELISA compared with those who were IgM-RF-negative (P = .0003). When a small group of individual children with polyarticular disease were followed longitudinally, similar correlations were found between severity of acute disease and the presence of IgM-RFs detected by ELISA. In children with pauciarticular JRA, expression of IgM-RFs appeared to be a transient phenomenon with no correlation with either articular disease or laboratory abnormalities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437439

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Is measurement of IgM and IgA rheumatoid factors (RF) in juvenile rheumatoid arthritis clinically useful?

Authors:  Rosa A Ferreira; Carlos H M Silva; Deise A O Silva; Monica C Sopelete; Maria H B Kiss; Jose R Mineo; Virginia P L Ferriani
Journal:  Rheumatol Int       Date:  2006-09-29       Impact factor: 2.631

2.  Serum IgM rheumatoid factor by enzyme-linked immunosorbent assay (ELISA) delineates a subset of patients with deforming joint disease in seronegative juvenile rheumatoid arthritis.

Authors:  A Aggarwal; S Dabadghao; S Naik; R Misra
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

Review 3.  Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology.

Authors:  Reema H Syed; Brooke E Gilliam; Terry L Moore
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

4.  Composition and biological behaviour of immune complexes isolated from synovial fluid of patients with juvenile rheumatoid arthritis (JRA).

Authors:  J N Jarvis; M M Diebold; M K Chadwell; M Iobidze; H T Moore
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

5.  Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis.

Authors:  James N Jarvis; Howard R Petty; Yuhong Tang; Mark Barton Frank; Philippe A Tessier; Igor Dozmorov; Kaiyu Jiang; Andrei Kindzelski; Yanmin Chen; Craig Cadwell; Mary Turner; Peter Szodoray; Julie L McGhee; Michael Centola
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

6.  Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis.

Authors:  James N Jarvis; Igor Dozmorov; Kaiyu Jiang; Mark Barton Frank; Peter Szodoray; Philip Alex; Michael Centola
Journal:  Arthritis Res Ther       Date:  2003-11-06       Impact factor: 5.156

7.  Whole blood gene expression profiling predicts therapeutic response at six months in patients with polyarticular juvenile idiopathic arthritis.

Authors:  Kaiyu Jiang; Ashley D Sawle; M Barton Frank; Yanmin Chen; Carol A Wallace; James N Jarvis
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.